KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBIT: 2020-2025

Historic EBIT for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $11.8 million.

  • Hims & Hers Health's EBIT fell 47.23% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.0 million, marking a year-over-year increase of 168.08%. This contributed to the annual value of $61.9 million for FY2024, which is 310.18% up from last year.
  • Latest data reveals that Hims & Hers Health reported EBIT of $11.8 million as of Q3 2025, which was down 55.82% from $26.7 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBIT ranged from a high of $57.9 million in Q1 2025 and a low of -$48.4 million during Q1 2021.
  • Over the past 3 years, Hims & Hers Health's median EBIT value was $11.0 million (recorded in 2024), while the average stood at $11.7 million.
  • Its EBIT has fluctuated over the past 5 years, first slumped by 1,678.04% in 2021, then soared by 4,749.00% in 2024.
  • Quarterly analysis of 5 years shows Hims & Hers Health's EBIT stood at -$21.6 million in 2021, then skyrocketed by 46.19% to -$11.6 million in 2022, then soared by 96.55% to -$400,000 in 2023, then spiked by 4,749.00% to $18.6 million in 2024, then tumbled by 47.23% to $11.8 million in 2025.
  • Its EBIT was $11.8 million in Q3 2025, compared to $26.7 million in Q2 2025 and $57.9 million in Q1 2025.